Radiologist Predicts Increased Role for Tomosynthesis in Bre
Digital breast tomosynthesis (DBT) may be the future of mammography screening, replacing traditional two-dimensional (2-D) and becoming the new standard of care, or so Sarah Friedewald, MD, a radiologist at the Lurie Cancer Center at Northwestern University, in Chicago, predicts. Other experts are not so certain about DBT’s role, however, saying that the benefits of DBT are incremental.

In a presentation at the 2016 Lynn Sage Breast Cancer Symposium, Dr. Friedewald made a strong pitch for routine use of DBT—approved by the FDA in 2011—noting that the technique has been shown to increase the detection of cancers and decrease the rate at which women are recalled for follow-up exams on suspicious screening results. She said DBT is particularly valuable for screening heterogeneously dense breast tissue because standard 2-D mammography can miss cancers in this type of tissue....